Cytoplasm-predominant Pten associates with increased region-specific brain tyrosine hydroxylase and dopamine D2 receptors in mouse model with autistic traits.

Erratum to: Cytoplasm-predominant Pten associates with increased region-specific brain tyrosine hydroxylase and dopamine D2 receptors in mouse model with autistic traits. Mol Autism (2016) 0.75

Germline mutations of the PTEN gene in Cowden disease, an inherited breast and thyroid cancer syndrome. Nat Genet (1997) 10.71

The dopamine D2 receptor locus as a modifying gene in neuropsychiatric disorders. JAMA (1991) 5.84

PTEN modulates cell cycle progression and cell survival by regulating phosphatidylinositol 3,4,5,-trisphosphate and Akt/protein kinase B signaling pathway. Proc Natl Acad Sci U S A (1999) 4.90

Subset of individuals with autism spectrum disorders and extreme macrocephaly associated with germline PTEN tumour suppressor gene mutations. J Med Genet (2005) 4.14

CREB is a regulatory target for the protein kinase Akt/PKB. J Biol Chem (1998) 4.12

Tyrosine hydroxylase phosphorylation: regulation and consequences. J Neurochem (2004) 2.04

De novo mutation in the dopamine transporter gene associates dopamine dysfunction with autism spectrum disorder. Mol Psychiatry (2013) 1.93

Long-term effects of risperidone in children with autism spectrum disorders: a placebo discontinuation study. J Am Acad Child Adolesc Psychiatry (2005) 1.71

PTEN inhibits insulin-stimulated MEK/MAPK activation and cell growth by blocking IRS-1 phosphorylation and IRS-1/Grb-2/Sos complex formation in a breast cancer model. Hum Mol Genet (2001) 1.69

Confirmation study of PTEN mutations among individuals with autism or developmental delays/mental retardation and macrocephaly. Autism Res (2010) 1.60

Phosphatase and tensin homolog, deleted on chromosome 10 deficiency in brain causes defects in synaptic structure, transmission and plasticity, and myelination abnormalities. Neuroscience (2007) 1.59

Brain serotonin and dopamine transporter bindings in adults with high-functioning autism. Arch Gen Psychiatry (2010) 1.53

Germline PTEN mutations in Cowden syndrome-like families. J Med Genet (1998) 1.51

Analysis of prevalence and degree of macrocephaly in patients with germline PTEN mutations and of brain weight in Pten knock-in murine model. Eur J Hum Genet (2011) 1.25

Germline disruption of Pten localization causes enhanced sex-dependent social motivation and increased glial production. Hum Mol Genet (2014) 1.18

Neural stem cells in the developing and adult brains. J Cell Physiol (2009) 1.11

Cyclin-dependent kinase 5 phosphorylates serine 31 of tyrosine hydroxylase and regulates its stability. J Biol Chem (2004) 1.07

Inhibition of neuronal phenotype by PTEN in PC12 cells. Proc Natl Acad Sci U S A (2004) 1.05

Pten ablation in adult dopaminergic neurons is neuroprotective in Parkinson's disease models. FASEB J (2011) 1.05

Selective deletion of PTEN in dopamine neurons leads to trophic effects and adaptation of striatal medium spiny projecting neurons. PLoS One (2009) 1.00

Germline and somatic cancer-associated mutations in the ATP-binding motifs of PTEN influence its subcellular localization and tumor suppressive function. Hum Mol Genet (2009) 1.00

SLC6A3 coding variant Ala559Val found in two autism probands alters dopamine transporter function and trafficking. Transl Psychiatry (2014) 1.00

Genetics and genomics of autism spectrum disorder: embracing complexity. Hum Mol Genet (2015) 1.00

Pten haploinsufficient mice show broad brain overgrowth but selective impairments in autism-relevant behavioral tests. Hum Mol Genet (2014) 0.92

PTEN deletion enhances survival, neurite outgrowth and function of dopamine neuron grafts to MitoPark mice. Brain (2012) 0.91

Pten Mutations Alter Brain Growth Trajectory and Allocation of Cell Types through Elevated β-Catenin Signaling. J Neurosci (2015) 0.90

Rare autism-associated variants implicate syntaxin 1 (STX1 R26Q) phosphorylation and the dopamine transporter (hDAT R51W) in dopamine neurotransmission and behaviors. EBioMedicine (2015) 0.89

DRD2 and PPP1R1B (DARPP-32) polymorphisms independently confer increased risk for autism spectrum disorders and additively predict affected status in male-only affected sib-pair families. Behav Brain Funct (2012) 0.88

Brief report: the dopamine-3-receptor gene (DRD3) is associated with specific repetitive behavior in autism spectrum disorder (ASD). J Autism Dev Disord (2012) 0.88

Catecholamines metabolism in infantile autism: a controlled study of 22 autistic children. J Autism Dev Disord (1987) 0.86

Urinary free and conjugated catecholamines and metabolites in autistic children. J Autism Dev Disord (1988) 0.86

Clinical presentation of PTEN mutations in childhood in the absence of family history of Cowden syndrome. Eur J Paediatr Neurol (2014) 0.84

Autism-epilepsy phenotype with macrocephaly suggests PTEN, but not GLIALCAM, genetic screening. BMC Med Genet (2014) 0.83

Molecular and phenotypic abnormalities in individuals with germline heterozygous PTEN mutations and autism. Mol Psychiatry (2014) 0.83

PTEN negatively regulates MAPK signaling during Caenorhabditis elegans vulval development. PLoS Genet (2012) 0.83

Language impairment and dyslexia genes influence language skills in children with autism spectrum disorders. Autism Res (2014) 0.82

Decreased aggression and increased repetitive behavior in Pten haploinsufficient mice. Genes Brain Behav (2015) 0.81

Brain patterning perturbations following PTEN loss. Front Mol Neurosci (2014) 0.77

Erratum to: Cytoplasm-predominant Pten associates with increased region-specific brain tyrosine hydroxylase and dopamine D2 receptors in mouse model with autistic traits. Mol Autism (2016) 0.75